John Ruffolo Insider Profile
4 Followers
John Ruffolo, Director at NervGen Pharma, holds 79.20K shares in NervGen Pharma (Ticker: NGEN), holds 20.00K shares in Ether Capital (Ticker: DTSRF). Most recently, John Ruffolo Bought ― shares of NervGen Pharma on Jun 02, 2026 for an estimated value of $18.27K.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+22.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that John Ruffolo holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Ruffolo
John Ruffolo's Trading History
NervGen Pharma
Jun 02, 2026
Director
Informative Buy
18.27K
$173.44K
Ether Capital
―
―
―
$53.00K
List of latest transactions for each holding click on a transaction to see John Ruffolo's performance on stock
You May Also Like
John Ruffolo insider profile FAQ
What is the percentage of profitable transactions made by John Ruffolo?
The percentage of profitable transactions made by John Ruffolo is 100%.
What is the average return per transaction made by John Ruffolo?
The average return per transaction made by John Ruffolo is 22.90%.
What stocks does John Ruffolo hold?
John Ruffolo holds: NGEN, DTSRF stocks.
What was John Ruffolo’s latest transaction?
John Ruffolo latest transaction was an Informative Buy of $18.27K.
What was John Ruffolo's most profitable transaction?
John Ruffolo’s most profitable transaction was an Informative Buy of NGEN stock on April 6, 2024. The return on the trade was 26.20%.
What is John Ruffolo's role in NervGen Pharma?
John Ruffolo's role in NervGen Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.